Recs

1

Google Prescribes More Partners

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

It's only been a few months since Google (NYSE: GOOG  ) launched its new health-information aggregation service, but it's already racked up quite a few partners in an effort to overtake Microsoft (Nasdaq: MSFT  ) , WebMD (Nasdaq: WBMD  ) , and Revolution Health, which all predated Google's efforts with similar websites to store health-care information.

Making importing your medical data easy is the key to successfully getting people to use the service. Who the heck would want to have to type in every drug they've ever taken, or decipher their doctor's chicken scratch?

Google Health's founding partners -- CVS Caremark (NYSE: CVS  ) , Walgreen (NYSE: WAG  ) , mail-order benefit manager MedcoHealth Solutions (NYSE: MHS  ) , and laboratory-testing company Quest Diagnostics (NYSE: DGX  ) just to name a few -- were all a good start, but the search giant has apparently gone up the food chain to sign up the mother of all pharmacy clients.

Instead of signing up each individual client, Google Health is partnering with PDX, a provider of client tracking software to almost 3,000 pharmacies. Now, 55 million customers could potentially integrate their pharmaceutical records into Google Health.

Since PDX is just the software maker, Google Health will still have to sign up the pharmacies individually, but the pitch shouldn't be nearly as hard, since PDX has done all the work to create seamless integration between the pharmacies' databases and Google Health.

Until Google Health establishes a way to get most doctors' records into its system, I think it'll probably remain a niche product, but the partnership with PDX definitely shows that Google has the right prescription for success.

More Foolishness Googled up for you:

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Microsoft and Quest Diagnostics are Motley Fool Inside Value selections. Google is a Motley Fool Rule Breakers pick. MedcoHealth Solutions is a Motley Fool Stock Advisor recommendation. Try any of our Foolish newsletters today, free for 30 days

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 716542, ~/Articles/ArticleHandler.aspx, 2/15/2012 12:04:19 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 hour ago Sponsored by:
DOW 12,878.28 4.24 0.03%
S&P 500 1,350.50 -1.27 -0.09%
NASD 2,931.83 0.44 0.02%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/14/2012 4:00 PM
MSFT $30.25 Down -0.13 -0.43%
Microsoft Corp CAPS Rating: ***
WAG $34.63 Down -0.16 -0.46%
Walgreen Company CAPS Rating: ****
WBMD $27.29 Up +0.18 +0.66%
WebMD Health Corp. CAPS Rating: **
CVS $43.38 Up +0.55 +1.28%
CVS Caremark Corp CAPS Rating: *****
DGX $57.49 Down -0.18 -0.31%
Quest Diagnostics,… CAPS Rating: ***
MHS $62.90 Up +1.96 +3.22%
Medco Health Solut… CAPS Rating: *****

Advertisement